Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ista, Tanabe Seiyaku deal

Tanabe granted ISTA exclusive rights to develop and commercialize nasal forms of bepotastine in North American

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE